Patents Assigned to Sepal Pharma Ltd.
  • Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
    Patent number: 9284252
    Abstract: The present invention relates to methods of treating benign hyperproliferative diseases of the epidermis by administering a composition comprising at least one jasmonate ester derivative. In particular, the present invention provides jasmonate ester derivatives as potent compounds useful for the treatment of disorders such as actinic keratoses with reduced side effects.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: March 15, 2016
    Assignee: SEPAL PHARMA LTD.
    Inventors: Max Herzberg, Frederic Revah
  • USE OF JASMONATE ESTER DERIVATIVES FOR TREATING BENIGN HYPERPROLIFERATIVE SKIN DISORDERS
    Publication number: 20150080430
    Abstract: The present invention relates to methods of treating benign hyperproliferative diseases of the epidermis by administering a composition comprising at least one jasmonate ester derivative. In particular, the present invention provides jasmonate ester derivatives as potent compounds useful for the treatment of disorders such as actinic keratoses with reduced side effects.
    Type: Application
    Filed: September 25, 2014
    Publication date: March 19, 2015
    Applicant: SEPAL PHARMA LTD.
    Inventors: Max HERZBERG, Frederic REVAH
  • CHEMICAL DERIVATIVES OF JASMONATE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20130203689
    Abstract: The present invention relates to novel jasmonate derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for prevention and treatment of cancers.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 8, 2013
    Applicants: SEPAL PHARMA LTD., RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: RAMOT AT TEL-AVIV UNIVERSITY LTD., SEPAL PHARMA LTD.
  • Jasmonate derivatives, pharmaceutical compositions and methods of use thereof
    Patent number: 8247439
    Abstract: The present invention relates to novel jasmonate derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for prevention and treatment of cancers.
    Type: Grant
    Filed: December 7, 2006
    Date of Patent: August 21, 2012
    Assignee: Sepal Pharma Ltd.
    Inventors: Max Herzberg, Adrian Harel, Christian Mang